Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-18

Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating rituximab with combination chemotherapy in older patients with previously untreated B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: German High-Grade Non-Hodgkin's Lymphoma Study Group | Conditions: Lymphoma | Phase 2 | Status: COMPLETED